| abstract |
The present invention relates to substituted pyrazolopyrimidinylamino-indazole compounds of general formula I as described and defined herein, methods for preparing the compounds, intermediate compounds useful for the preparation of the compounds, pharmaceutical compositions comprising the compounds Of the above compounds as sole agents or in combination with other active ingredients for the manufacture of pharmaceutical compositions for the treatment or prevention of diseases, in particular hyperproliferation and / or angiogenic disorders Regarding use. |